When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ZGNX - Zogenix down 33% after hours on positive Fintepla data in Lennox-Gastaut
Zogenix Inc.
Zogenix (NASDAQ:ZGNX) slumps 33% after hours in reaction to its announcement of "successful" results from a Phase 3 clinical trial evaluating two doses of Fintepla (fenfluramine oral solution) (ZX008) in patients with a severe form of childhood-onset epilepsy called Lennox-Gastaut syndrome.
More news on: Zogenix, Inc., GW Pharmaceuticals plc, Healthcare stocks news, Stocks on the move,